The cytotoxicity of DNA carboxymethylation and methylation by the model carboxymethylating agent azaserine in human cells

Carcinogenesis

Volumn 20, Issue 9, 1999, Pages 1855-1862

  O'Driscoll, M ^b   Macpherson, P ^b   Xu, Yao Zhong ^a   Karran, P ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

6 O METHYLGUANINE; ACETIC ACID DERIVATIVE; AZASERINE; DNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ARTICLE; BURKITT LYMPHOMA; CONTROLLED STUDY; DNA DAMAGE; DNA METHYLATION; DRUG CYTOTOXICITY; DRUG SENSITIVITY; EXCISION REPAIR; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL LINE; PRIORITY JOURNAL; RAJI CELL; XERODERMA PIGMENTOSUM;

ADENINE; ALKYLATING AGENTS; AZASERINE; AZO COMPOUNDS; BURKITT LYMPHOMA; CARCINOGENS; DNA ADDUCTS; DNA DAMAGE; DNA METHYLATION; DRUG RESISTANCE; ENZYME INDUCTION; GENETIC COMPLEMENTATION TEST; GLYCINE; GUANINE; HUMANS; LYMPHOCYTES; METHYLATION; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; TUMOR CELLS, CULTURED; XERODERMA PIGMENTOSUM;

EID: 0032871478     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.9.1855     Document Type: Article

References (48)

1. Lindahl, T. (1996) Endogenous damage to DNA. Phil. Trans. R. Soc. Lond., 351, 1529-1538.
2. Pegg, A.E., Dolan, M.E. and Moschel, R.C. (1995) Structure, function and inhibition of 06-alkylguanine-DNA alkyltransferase. Prog. Nucleic Acid Res. Mol. Biol., 51, 170-223.
3. Karran, P. and Bignami, M. (1992) Self-destruction and tolerance in resistance of mammalian cells to alkylation damage. Nucleic Acids Res., 20, 2933-2940.
4. Kat, A., Thilly, W.G., Fang, W.H., Longley, M.J., Li, G.M. and Modrich, P. (1993) An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair. Proc. Natl Acad. Sci. USA, 90, 6424-6428.
5. Hampson, R., Humbert, O., Macpherson, P., Aquilina, G. and Karran, P. (1997) Mismatch repair defects and O6-methylguanine-DNA methyltransferase expression in acquired resistance to methylating agents in human cells. J. Biol. Chem., 272, 28596-28606.
6. O'Driscoll, M., Martinelli, S., Ciotta, C. and Karran, P. (1999) Combined mismatch and nucleotide excision repair defects in a human cell line: mismatch repair processes methylation but not UV-or ionizing radiation-induced DNA damage. Carcinogenesis, 20, 799-804.
7. Ceccotti, S., Aquilina, G., Macpherson, P., Yamada, M., Karran, P. and Bignami, M. (1996) Processing of O6-methylguanine by mismatch correction in human cell extracts. Curr. Biol., 6, 1528-1531.
8. Ciotta, C., Ceccotti, S., Aquilina, G., Humbert, O., Palombo, F., Jiricny, J. and Bignami, M. (1998) Increased somatic recombination in methylation tolerant cells with defective mismatch repair. J. Mol. Biol., 276, 705-719.
9. Koi, M., Umar, A., Chauhan, D.P., Cherian, S.P., Carethers, J.M., Kunkel, T.A. and Boland, C.R. (1994) Human chromosome 3 corrects mismatch repair deficiency and microsatellite instability and reduces N-methyl-N′-nitro-N-nitrosoguanidine tolerance in colon tumor cells with homozygous hMLH1 mutation. Cancer Res., 54, 4308-4312.
10. Branch, P., Hampson, R. and Karran, P. (1995) DNA mismatch binding defects, DNA damage tolerance, and mutator phenotypes in human colorectal carcinoma cell lines. Cancer Res., 55, 2304-2309.
11. Umar, A., Koi, M., Risinger, J.I., Glaab, W.E., Tindall, K.R., Kolodner, R.D., Boland, C.R., Barett, J.C. and Kunkel, T.A. (1997) Correction of hypermutability, N-methyl-N′-nitro-N-nitrosoguanidine resistance, and defective DNA mismatch repair by introducing chromosome 2 into human tumor cells with mutations in MSH2 and MSH6. Cancer Res., 57, 3949-3955.
12. Aquilina, G., Ceccotti, S., Martinelli, S., Hampson, R. and Bignami, M. (1998) CCNU-sensitivity in mismatch repair defective human cells. Cancer Res., 58, 135-141.
13. Karran, P. and Bignami, M. (1994) DNA damage tolerance, mismatch repair and genome instability. Bioessays, 16, 833-839.
14. Shuker, D.E.G. and Margison, G.P. (1997) Nitrosated glycine derivatives as a potential source of O6-methylguanine in DNA. Cancer Res., 57, 366-369.
15. Rydberg, B. and Lindahl, T. (1982) Nonenzymatic methylation of DNA by the intracellular methyl group donor S-adenosyl-L-methionine is a potentially mutagenic reaction. EMBO J., 1, 211-216.
16. Taverna, P. and Sedgwick, B. (1996) Generation of an endogenous DNA methylating agent by nitrosation in Escherichia coli. J. Bacteriol., 178, 5105-5111.
17. 6-alkylguanine-DNA alkyltransferase deficient cells. Carcinogenesis, 18, 1561-1567.
18. Goldin, B.R. (1986) In situ bacterial metabolism and colon mutagens. Annu. Rev. Microbiol., 40, 367-393.
19. Hill, M.J. (1990) Bile flow and colon cancer. Mutat. Res., 238, 313-320.
20. Puju, S., Shuker, D.E.G., Bishop, W.W., Falchuk, K.R., Tannenbaum, S.R. and Thilly, W.G. (1982) Mutagenicity of N-nitroso bile acid conjugates in Samonella typhimurium and diploid human lymphoblasts. Cancer Res., 42, 2601-2604.
21. Levenberg, B., Melnich, J. and Buchanan, J.M. (1957) Biological synthesis of the purines, XV. The effect of aza-L-serine and 6-diazo-5-oxo-norleucine on inosinic acid biosynthesis de novo. J. Biol. Chem., 225, 163-176.
22. Lyons, S.D., Sant, M.E. and Christopherson, R.I. (1990) Cytotoxic mechanism of glutamine antagonists in mouse L1210 leukemia. J. Biol. Chem., 265, 11377-11381.
23. Zurlo, J., Curphey, T.J., Hiley, R. and Longnecker, D. (1982) Identification of 7-carboxymethylguanine in DNA from pancreatic actinar cells exposed to azaserine. Cancer Res., 42, 1286-1288.
24. Harrison, K.L., Fairhurst, N., Challis, B.C. and Shuker, D.E.G. (1997) Synthesis, characterization and immunochemical detection of O6-(carboxymethyl)-2′-deoxyguanosine: a DNA adduct formed by nitrosated glycine derivatives. Chem. Res. Toxicol., 10, 652-659.
25. Friedberg, E.C., Walker, G.C. and Siede, W. (1995) DNA Repair and Mutagenesis. ASM Press, Washington, DC.
26. Griffin, S., Branch, P., Xu, Y.-Z. and Karran, P. (1994) DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: implications for tolerance to DNA damage. Biochemistry, 33, 4787-4793.
27. Macpherson, P., Humbert, O. and Karran, P. (1998) Frameshift mismatch recognition by the human MutSa complex. Mutat. Res., 408, 55-66.
28. Xu, Y.-Z. (1998) Reactive DNA 2. Thioguanine used as a peg site for direct and specific introduction of biologically useful functional groups. Bioorg. Med. Chem., 8, 1839-1844.
29. Xu, Y.-Z., Zheng, Q. and Swann, P.F. (1992) Synthesis by post-synthetic substitution of oligomers containing guanine modified at the 6-position with S-, N-, O-derivatives. Tetrahedron, 48, 1729-1742.
30. Xu, Y.-Z. and Swann, P.F. (1992) Chromatographic separation of oligodeoxynucleotides with identical length: application to purification of oligomers containing a modified base. Anal. Biochem., 204, 185-189.
31. Branch, P., Aquilina, G., Bignami, M. and Karran, P. (1993) Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage. Nature, 362, 652-654.
32. Drummond, J.T., Li, G.-M., Longley, M.J. and Modrich, P. (1995) Isolation of an hMSH2-p160 heterodimer that restores DNA mismatch repair to tumor cells. Science, 268, 1909-1912.
33. Habig, W.H., Pabst, M.J. and Jakoby, W.B. (1974) The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249, 7130-7139.
34. Lilya, H.S., Longnecker, D.S., Curphey, T.S., Daniel, D.S. and Adams, W.E. (1981) Studies of DNA damage in rat pancreas and liver by 6-diazo-5-oxo-L-norleucine, ethyl diazoacetate and azaserine. Cancer Lett., 12, 139-146.
35. Perantoni, A., Rice, J.M., Nardone, R.M., Herman, J.J. and Curphey, T.J. (1984) The function of γ-glutamyl transpeptidase as a determinant in cell sensitivity to azaserine toxicity. Chem. Biol. Interact., 52, 39-50.
36. Hanigan, M.H. (1998) γ-Glutamyltranspeptidase, a glutathionase: its expression and function in Carcinogenesis. Chem. Biol. Interact., 111/112, 333-342.
37. Perantoni, A., Berman, J.J. and Rice, J.M. (1979) L-Azaserine toxicity in established cell lines. Correlation with γ-glutamyl transpeptidase activity. Exp. Cell Res., 122, 55-61.
38. Nakagawa, K., Saijo, N., Tsuchida, S., Sakai, M., Tsunokawa, Y., Yokota, J., Muramatsu, M., Sato, K., Terada, M. and Tew, K.D. (1990) Glutathione-S-transferase π as a determinant of drug resistance in transfectant cell lines. J. Biol. Chem., 265, 4296-4301.
39. Peters, W.H.M. and Roelofs, H.M.J. (1992) Biochemical characterization of resistance to mitoxantrone and adriamycin in CaCo-2 human colon adenocarcinoma cells: a possible role for glutathione-S-transferases. Cancer Res., 52, 1886-1890.
40. Harrison, K.L., Jukes, R., Cooper, D.P. and Shuker, D.E.G. (1999) Determination of concomitant formation of O6-carboxymethy-and O6-methyl-2′-deoxyguanosine in DNA exposed to nitrosated glycine derivatives using a combined immunoaffinity-HPLC method. Chem. Res. Toxicol., 12, 106-111.
41. Duckett, D.R., Drummond, J.T., Murchie, A.I.H., Reardon, J.T, Sancar, A., Lilley, D.M. and Modrich, P. (1996) Human MutSa recognizes damaged DNA base pairs containing O6-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct. Proc. Natl Acad. Sci. USA, 93, 6443-6447.
42. Genschel, J., Littman, S.J., Drummond, J.T. and Modrich, P. (1998) Isolation of MutSβ from human cells and comparison of the mismatch repair specificities of MutSβ and MutSα. J. Biol. Chem., 273, 19895-19901.
43. Kubitschek, H.E. and Sepanski, R.J. (1982) Azaserine: survival and mutation in Escherichia coli Mutat. Res., 94, 31-38.
44. Williams-Hill, D.M., Olesen, J., Zucker, C. and Kubitschek, H.E. (1984) Azaserine: further evidence for DNA damage in Escherichia coli. Mutat. Res., 129, 153-164.
45. Matijasevic, Z., Boosalis, M., Mackay, W., Samson, L. and Ludlum, D.B. (1993) Protection against chloroethylnitrosourea cytotoxicity by eukaryotic 3-methyladenine DNA glycosylase. Proc. Natl Acad. Sci. USA, 90, 11855-11859.
46. Saparbaev, M. and Laval, J. (1994) Excision of hypoxanthine from DNA containing dIMP residues by the Escherichia coli, yeast, rat and human alkylpurine DNA glycosylases. Proc. Natl Acad. Sci. USA, 91, 5873-5877.
47. Hang, B., Singer, B., Margison, G.P. and Elder, R.H. (1997) Targeted deletion of alkylpurine-DNA-N-glycosylase in mice eliminates repair of 1,N6-ethenoadenine and hypoxanthine but not of 3,N4-ethenocytosine or 8-oxoguanine. Proc. Natl Acad. Sci. USA, 94, 12869-12874.
48. Longnecker, D.S. and Curphey, T.J. (1975) Adenocarcinoma of the pancreas in azaserine-treated rats. Cancer Res., 35, 2249-2258.